Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery

Clinical Trial ID NCT01276496

PubWeight™ 3.41‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01276496

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Emerging targeted agents in metastatic breast cancer. Nat Rev Clin Oncol 2013 1.59
2 Therapeutic targets for bone metastases in breast cancer. Breast Cancer Res 2011 1.16
3 Antiangiogenic mechanisms and factors in breast cancer treatment. J Carcinog 2016 0.75
Next 100